NU SOURCE NATURALS GREENS DAILY DETOX
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Vaccinium myrtillus Fonte : Fruit (standardized extract) Rapporto di estrazione : 100:1 Equivalente di pianta secca : 1.000 mg Potenza : 25 % Anthocyanidins | 10 mg | Non calcolata |
| Linum usitatissimum Fonte : Graine(s) | 100 mg | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus limon - Pelure (fruit) | 100 mg | Non calcolata |
| Lécithine Fonte : Soya oil - standardized extract Potenza : 521 mg Phosphatidylcholine | 2.171 mg | Non calcolata |
| Lécithine Fonte : Soya oil - standardized extract Potenza : 434 mg Phosphatidylethanolamine | Non precisata | Non calcolata |
| Lécithine Fonte : Soya oil - standardized extract Potenza : 304 mg Phosphatidylinositol | Non precisata | Non calcolata |
| Vitis vinifera Fonte : pulp, skin and seed (standardized extract) Potenza : 5 % Resveratrol | Non precisata | Non calcolata |
| Acide L-alpha-acétamido-bêta-mercaptopropionique | 100 mg | Non calcolata |
| Molybdène Fonte : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH) | 100 mcg | Non calcolata |
| Magnésium Fonte : Aspartate de magnésium | 100 mg | Non calcolata |
| Acide aminoacétique Fonte : L-Glycine | 500 mg | Non calcolata |
| Cynara cardunculus Fonte : Extrait de Feuille Rapporto di estrazione : 4:1 Equivalente di pianta secca : 400 mg | 100 mg | Non calcolata |
| Acide 2-aminoéthanesulfonique Fonte : L-Taurine | 50 mg | Non calcolata |
| Fibre de fruits et légumes Fonte : Malus domestica - fibre | 1.033 mg | Non calcolata |
| Glycyrrhiza glabra Fonte : Root (standardized extract) Potenza : 10 % Glycyrrhizic acid | 116 mg | Non calcolata |
| Oryza sativa Fonte : Graine(s) | 383 mg | Non calcolata |
| Taraxacum officinale Fonte : Racine | 100 mg | Non calcolata |
| Beta vulgaris Fonte : Racine | 386 mg | Non calcolata |
Ingredienti non medicinali
D-Malic acid, Saveur, Dioxyde de silicium, Citric acid, Saveur de baies, Feuille de stevia rebaudiana
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | 1 Mesures | 1 Tous les jours |
Usi autorizzati in Canada
Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps to maintain proper muscle function. Helps to support liver function.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Cautions and Warnings : If seal around cap is broken or missing, do not use. Consult a healthcare practitioner prior to use if are taking nitroglycerin, antibiotics, any prescription medications, if you have gallstones, any type of acute infection, a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice), an iron deficiency, cystinuria, and/or diabetes. Do not use if you are pregnant or breastfeeding, or if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you have a bile duct obstruction, hypokalemia, high blood pressure, a kidney or cardiovascular disorder, or if you have a history of asthma or allergies. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family or bee products or pollen. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use.
Testo originale in inglese.
Scheda del prodotto
- Titolare
- Lifeagen Biosciences of Florida, Inc. dba Health and Nutrition Systems
- NPN o DIN-HM
- 80044540
- Stato
- Licenza attiva
- Data della licenza
- 3 settembre 2013
- Data di revisione
- Non indicata
- Forma
- Poudre
- Via di somministrazione
- Orale
- Tipo di domanda
- Non traditionnelle
Fonte
Scheda ufficiale Health Canada, licenza 80044540
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Vaccinium myrtillus
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Via di somministrazione: Buccal (Blumenthal et al. 2000)
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 30 gennaio 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Via di somministrazione: Oral (Blumenthal et al. 2000)
Precauzioni e avvertenze
Condizione di applicazione: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Linum usitatissimum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
FLAXSEED - LINUM USITATISSIMUM
Via di somministrazione: Oral
Precauzioni e avvertenze
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Fonti citate da Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condizione di applicazione: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Fonti citate da Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Controindicazioni
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Fonti citate da Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Reazioni avverse note
Condizione di applicazione: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- Lécithine
Leggere l'avvertenza, quando si applica e gli studi citati
- Cynara cardunculus
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Globe Artichoke - Cynara Cardunculus
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003).
Fonti citate da Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones (Brinker 2010; Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000).
Fonti citate da Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Condizione di applicazione: Digestive disturbance/dyspepsia/Help increase bile flow.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Controindicazioni
Do not use if you have a bile duct obstruction (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
Fonti citate da Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), March 27, 2018. [Accessed 2025 December 30]. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cynara-cardunculus-l-syn-cynara-scolymus-l-folium_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
Fonti citate da Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), March 27, 2018. [Accessed 2025 December 30]. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cynara-cardunculus-l-syn-cynara-scolymus-l-folium_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Glycyrrhiza glabra
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
DEGLYCYRRHIZINATED LICORICE Buccal
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 31 ottobre 2025
Deglycyrrhizinated Licorice Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 31 gennaio 2025
LICORICE
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
Fonti citate da Health Canada (1)
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
Condizione di applicazione: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
Fonti citate da Health Canada (1)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
Condizione di applicazione: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Controindicazioni
Condizione di applicazione: All products.
Do not use if you are pregnant (EMA 2012).
Fonti citate da Health Canada (2)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
Fonti citate da Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
Fonti citate da Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.